Fed. Circ. Says Merck Atty's Lies Doomed $200M Patent Win
The Federal Circuit upheld a decision wiping out a $200 million patent verdict Merck won against Gilead concerning hepatitis C drugs, agreeing Wednesday that "dishonest and duplicitous" behavior by a Merck in-house...To view the full article, register now.
Already a subscriber? Click here to view full article